Empagliflozin vs Enalapril
Empagliflozin vs Enalapril: Overview
This comparison examines the pharmacological differences between Empagliflozin and Enalapril.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Enalapril: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Enalapril β 11 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Enalapril β C20H28N2O5.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Enalapril β 376.4470 g/mol.
Type: Empagliflozin β Small molecule; Enalapril β Small molecule.